After halting Lumena buyout, Shire's liver disease drug flunks again
PSC is an uncommon chronic liver disease in which the bile ducts inside and outside the liver progressively decrease in size due to inflammation and scarring, which can lead to liver failure. Shire said that the primary objective of the study was to ...
FierceBiotech - Fri, 29 Apr 2016 06:31

UDCA fails to improve mortality in primary biliary cirrhosis
BARCELONA — The use of ursodeoxycholic acid for primary biliary cholangitis failed to reduce all-cause mortality, according to results of a systematic review presented at the International Liver Congress 2016.
Healio - Wed, 13 Apr 2016 05:01



FDA Panel Backs Approval of Liver-Disease Drug
While primary biliary cirrhosis is relatively rare, analysts believe Intercept's drug has big sales potential because the company also plans to seek regulatory approval for it to treat a more common liver disease known as nonalcoholic steatohepatitis ...
Wall Street Journal - Thu, 07 Apr 2016 14:38

Advisory Panel Backs Intercept's Liver Drug, FDA Ruling up Next
Xconomy - Thu, 07 Apr 2016 13:03

FDA staff finds Intercept's liver drug effective as monotherapy
Reuters - Tue, 05 Apr 2016 06:09

Intercept Pharma Shares Halted Ahead of FDA Committee Meeting on Primary ...
Sonoran Weekly Review - Thu, 07 Apr 2016 11:54

FDA Advisory Committee Unanimously Recommends Accelerated Approval of Ocaliva ...
GlobeNewswire (press release) - Thu, 07 Apr 2016 14:02

Intercept Pharmaceuticals Inc Gets One Step Closer to Explore the NAFLD Market
Business Finance News - Wed, 06 Apr 2016 11:56

Intercept surges as FDA review hesitates on endorsing OCA data, but doesn't ...
FierceBiotech - Tue, 05 Apr 2016 06:33

Intercept to Report First Quarter 2016 Financial Results on May 5
OCA is being developed to treat a variety of chronic liver diseases, including primary biliary cirrhosis, recently renamed primary biliary cholangitis (PBC), non-alcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC), and biliary ...
GlobeNewswire (press release) - Thu, 28 Apr 2016 13:37



My View: Curb step therapy, increase access to effective treatments
People with liver disease need to be especially aware — everything we eat, drink and breathe is processed by the liver, including all the medicines we ingest. ... Living with Hepatitis B, Hepatitis C and Primary Biliary Cirrhosis (PBC) is not easy. As ...
Freeport Journal-Standard - Thu, 28 Apr 2016 14:45

New therapy strategy for liver disease shows initial measureable success with ...
The new therapy strategy for primary sclerosing cholangitis, a liver disease that at present still cannot be cured with medication, shows initial measureable success with the nor-ursodeoxycholic acid (norUrso). ... following years of previous research ...
News-Medical.net - Tue, 19 Apr 2016 12:30

WFA+-M2BP levels linked to liver fibrosis, HCC progression in chronic HBV
... HBV infection", say the investigators, a finding that is in line with previous research demonstrating the value of WFA+-M2BP as a noninvasive liver fibrosis marker in other chronic liver diseases, such as hepatitis C virus infection and primary ...
News-Medical.net - Wed, 27 Apr 2016 14:11

Bolingbrook resident seeks liver transplant
Kelly Drey, daughter of retired Public Works Director Mike Drey, has developed a rare disease of the bile ducts that is causing her liver to fail. A liver transplant is her only hope to survive. She has been diagnosed with primary biliary cholangitis ...
The Bugle - Thu, 28 Apr 2016 09:30


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.